Package 43598-751-05

{"route": ["ORAL"], "spl_id": "1005fd33-b291-408a-8be3-6acaac39bebf", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993503", "993518", "993536"], "spl_set_id": ["ad784c8e-7201-4336-a310-616e3e979ca4"], "manufacturer_name": ["Dr. Reddys Laboratories Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43598-751-01)", "package_ndc": "43598-751-01", "marketing_start_date": "20180515"}, {"sample": false, "description": "500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43598-751-05)", "package_ndc": "43598-751-05", "marketing_start_date": "20180515"}, {"sample": false, "description": "60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43598-751-60)", "package_ndc": "43598-751-60", "marketing_start_date": "20180515"}], "brand_name": "Bupropion Hydrochloride SR", "product_id": "43598-751_1005fd33-b291-408a-8be3-6acaac39bebf", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "43598-751", "generic_name": "bupropion hydrochloride", "labeler_name": "Dr. Reddys Laboratories Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "SR", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "100 mg/1"}], "application_number": "ANDA205794", "marketing_category": "ANDA", "marketing_start_date": "20180515", "listing_expiration_date": "20271231"}